Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte
通过葡萄糖醛酸化处理黄酮类化合物,外排转运的关键作用
基本信息
- 批准号:9267482
- 负责人:
- 金额:$ 52.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-05 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:ABCG2 geneAnimal ModelAntioxidantsBasic ScienceBeta-glucuronidaseBioavailableBiologicalBiological AvailabilityBlood CirculationCardiovascular systemCell modelCholesterolClassificationColonComplexDegenerative DisorderDevelopmentDietary FlavonoidDrug CompoundingDrug DesignDrug KineticsEffectivenessEnteralEnzymesFlavonoidsGenisteinGlucuronidesGlucuronosyltransferaseGoalsHealthHealth BenefitHumanHydrolysisIn VitroIntestinal AbsorptionKineticsKnowledgeMalignant NeoplasmsMapsMathematicsMetabolicMetabolic PathwayMetabolismModelingMolecularMusOrganPharmaceutical PreparationsPhaseProcessProductionProtein IsoformsRecyclingResearchResearch Project GrantsResearch ProposalsRoleSafetyScienceStructureSystemTestingTimeTissuesUGT1A1 geneUnspecified or Sulfate Ion SulfatesValidationanti agingdesignenzyme activityhydrophilicityimprovedin vivoinhibitor/antagonistinnovationmathematical modeloverexpressionpractical applicationpreventpublic health relevancesulfotransferase
项目摘要
DESCRIPTION (provided by applicant): Dietary flavonoids exert a broad range of biological effects including anticancer, antioxidant, antiosteoperosis, cholesterol lowering, and anti-aging, which make them attractive for preventing cancer and cardiovascular ailments and for impeding the progress of degenerative diseases. However, these compounds are poorly bioavailable, which impedes their development as viable drugs. The long-term goal of our study is to determine how efflux transporters of hydrophilic phase II conjugates control the overall disposition of flavonoids and determine their biological fate in vivo. The central hypothesis for the present research proposal is that the local and systemic bioavailability of a flavonoid will be
improved by modulating the function of a critical efflux transporter responsible for its distributin to the local target organs (e.g., colon) or the systemic circulation. Our central hypothesis is a step beyond the classical hypothesis that bioavailabilities of drugs can only be improved if more are absorbed and/or less of the absorbed amount is metabolized. The Specific Aims of this renewal proposal are to: (1) construct precise quantitative cellular metabolic models to describe the kinetics of glucuronide formation and efflux at the molecular level; (2) determine the quantitative structure-efflux relationships (QSERs) for three key efflux transporters of flavonoid glucuronides: BCRP, MRP2, and MRP3; and (3) establish a glucuronidation classification system to map which flavonoid is likely to have good bioavailability by manipulating a particular efflux transporter. Successful completion of our research project will significantly advance the basic sciences as well as practical knowledge that may be used to improve the bioavailability of flavonoids and relevant drugs for human health.
描述(申请人提供):膳食类黄酮具有广泛的生物效应,包括抗癌、抗氧化、抗骨质疏松、降低胆固醇和抗衰老,这使得它们在预防癌症和心血管疾病以及阻止退行性疾病的进展方面具有吸引力。然而,这些化合物的生物利用度较差,这阻碍了它们作为可行药物的开发。我们研究的长期目标是确定亲水性 II 相缀合物的外排转运蛋白如何控制类黄酮的整体分布并确定它们在体内的生物命运。本研究计划的中心假设是类黄酮的局部和全身生物利用度将是
通过调节负责将其分配到局部靶器官(例如结肠)或全身循环的关键外排转运蛋白的功能来改善。我们的中心假设超越了经典假设,即只有更多的药物被吸收和/或更少的吸收量被代谢,药物的生物利用度才能提高。该更新提案的具体目标是:(1)构建精确的定量细胞代谢模型,以在分子水平上描述葡萄糖苷酸形成和流出的动力学; (2) 确定类黄酮葡萄糖苷酸的三个关键外排转运蛋白的定量结构-外排关系 (QSER):BCRP、MRP2 和 MRP3; (3) 建立葡萄糖醛酸化分类系统,通过操纵特定的外排转运蛋白来绘制哪些类黄酮可能具有良好的生物利用度。我们的研究项目的成功完成将极大地推进基础科学和实践知识的发展,这些知识可用于提高黄酮类化合物和相关药物对人类健康的生物利用度。
项目成果
期刊论文数量(81)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glucuronidation: driving factors and their impact on glucuronide disposition.
- DOI:10.1080/03602532.2017.1293682
- 发表时间:2017-05
- 期刊:
- 影响因子:5.9
- 作者:Yang G;Ge S;Singh R;Basu S;Shatzer K;Zen M;Liu J;Tu Y;Zhang C;Wei J;Shi J;Zhu L;Liu Z;Wang Y;Gao S;Hu M
- 通讯作者:Hu M
Regioselective glucuronidation of flavonols by six human UGT1A isoforms.
- DOI:10.1007/s11095-011-0418-5
- 发表时间:2011-08
- 期刊:
- 影响因子:3.7
- 作者:Wu, Baojian;Xu, Beibei;Hu, Ming
- 通讯作者:Hu, Ming
Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.
- DOI:10.1021/mp200300w
- 发表时间:2011-12-05
- 期刊:
- 影响因子:4.9
- 作者:Wu B;Zhang S;Hu M
- 通讯作者:Hu M
Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.
- DOI:10.3109/00498254.2012.663515
- 发表时间:2012-08
- 期刊:
- 影响因子:0
- 作者:Dong D;Ako R;Hu M;Wu B
- 通讯作者:Wu B
A new strategy to rapidly evaluate kinetics of glucuronide efflux by breast cancer resistance protein (BCRP/ABCG2).
- DOI:10.1007/s11095-012-0817-2
- 发表时间:2012-11
- 期刊:
- 影响因子:3.7
- 作者:Wu, Baojian;Jiang, Wen;Yin, Taijun;Gao, Song;Hu, Ming
- 通讯作者:Hu, Ming
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MING HU其他文献
MING HU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MING HU', 18)}}的其他基金
Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries
阐明丁丙诺啡的高口腔液暴露机制以减少龋齿
- 批准号:
10765181 - 财政年份:2023
- 资助金额:
$ 52.66万 - 项目类别:
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury
开发用于化疗引起的肠道损伤的药物解毒细菌
- 批准号:
10560782 - 财政年份:2021
- 资助金额:
$ 52.66万 - 项目类别:
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury
开发用于化疗引起的肠道损伤的药物解毒细菌
- 批准号:
10252721 - 财政年份:2021
- 资助金额:
$ 52.66万 - 项目类别:
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities
中药方剂小柴胡汤抗伊立替康肠道毒性的机制和药代动力学研究
- 批准号:
10262912 - 财政年份:2020
- 资助金额:
$ 52.66万 - 项目类别:
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities
中药方剂小柴胡汤抗伊立替康肠道毒性的机制和药代动力学研究
- 批准号:
10463682 - 财政年份:2020
- 资助金额:
$ 52.66万 - 项目类别:
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities
中药方剂小柴胡汤抗伊立替康肠道毒性的机制和药代动力学研究
- 批准号:
10686830 - 财政年份:2020
- 资助金额:
$ 52.66万 - 项目类别:
Inhibition of Oral Tumorigenesis by Antitumor B
抗肿瘤 B 抑制口腔肿瘤发生
- 批准号:
10516360 - 财政年份:2016
- 资助金额:
$ 52.66万 - 项目类别:
Inhibition of Oral Tumorigenesis by Antitumor B
抗肿瘤 B 抑制口腔肿瘤发生
- 批准号:
10170283 - 财政年份:2016
- 资助金额:
$ 52.66万 - 项目类别:
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte
通过葡萄糖醛酸化处理黄酮类化合物,外排转运的关键作用
- 批准号:
8870372 - 财政年份:2006
- 资助金额:
$ 52.66万 - 项目类别:
Disposition of Flavonoids via Metabolic Interplay
通过代谢相互作用处理黄酮类化合物
- 批准号:
7784367 - 财政年份:2006
- 资助金额:
$ 52.66万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 52.66万 - 项目类别:
Redox stress resilience in aging skeletal muscle
衰老骨骼肌的氧化还原应激恢复能力
- 批准号:
10722970 - 财政年份:2023
- 资助金额:
$ 52.66万 - 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
- 批准号:
10732666 - 财政年份:2023
- 资助金额:
$ 52.66万 - 项目类别: